Subscribe
trademark-istock-508118711-timarbaev-
timarbaev / iStockphoto.com
11 January 2019Medtech

Plastic surgery clinic targets former employees in copyright and TM suit

A New York-based plastic surgery clinic has taken legal action against two former employees and a rival clinic for copyright infringement, trademark counterfeiting and dilution, and cybersquatting.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Cosmetic surgery firm sued over ‘smaller breasts’ blog image
17 December 2018   A Florida-based photo agency has accused San Francisco Plastic Surgery & Laser Center of using a copyright-protected image without authorisation on a web page about breast implants.


Editor's picks

LSPN: In-house ‘chess game’ is the same, but the rules have changed
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

Editor's picks

Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

More on this story

Americas
Cosmetic surgery firm sued over ‘smaller breasts’ blog image
17 December 2018   A Florida-based photo agency has accused San Francisco Plastic Surgery & Laser Center of using a copyright-protected image without authorisation on a web page about breast implants.

More on this story

Americas
Cosmetic surgery firm sued over ‘smaller breasts’ blog image
17 December 2018   A Florida-based photo agency has accused San Francisco Plastic Surgery & Laser Center of using a copyright-protected image without authorisation on a web page about breast implants.

More features

As AI shakes up pharma and biotech, can patent law keep up?
UK court clears the way for Amgen and Samsung to launch biosimilars
SK Bioscience prevails over Pfizer in pneumococcal vaccine dispute
‘It’s going to be very different’: INTA CEO shares London meeting plans
'Scrap the billable hour': LSIPR joins INTA panel on gender diversity
Sanofi unit loses genetic disorder patent at EPO after trio of challenges
INTA confirms London as host city for Annual Meeting 2026
INTA unveils key principles on AI and IP rights at Annual Meeting